Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs in an attempt to curb their off-label ...

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

IF you’re on a weight loss jab, you’ll have a suppressed appetite and feel full quickly after eating – the ideal recipe for ...

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...

From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...

The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...